Back
Ligand Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
48
LGND
Ligand Pharmaceuticals
Last Price:
$113.45
Seasonality Move:
9.17%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGND is experiencing slight buying pressure.
Ligand Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 116.22 | Sell |
| 20-day SMA: | 118.94 | Sell |
| 50-day SMA: | 115.44 | Sell |
| 200-day SMA: | 95.77 | Buy |
| 8-day EMA: | 115.5 | Sell |
| 20-day EMA: | 116.95 | Sell |
| 50-day EMA: | 114.67 | Sell |
| 200-day EMA: | 99.24 | Buy |
Ligand Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 44.98 | Sell |
| Chaikin Money Flow: | 4519 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.3 - 122.38) | Sell |
| Bollinger Bands (100): | (100.62 - 116.98) | Buy |
Ligand Pharmaceuticals Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ligand Pharmaceuticals Stock
Is Ligand Pharmaceuticals Stock a Buy?
-
Ligand Pharmaceuticals share price is 113.38 while LGND 8-day simple moving average is 116.22, which is a Sell signal.
-
The stock price of LGND is 113.38 while Ligand Pharmaceuticals 20-day SMA is 118.94, which makes it a Sell.
-
Ligand Pharmaceuticals 50-day simple moving average is 115.44 while LGND share price is 113.38, making it a Sell technically.
-
LGND stock price is 113.38 and Ligand Pharmaceuticals 200-day simple moving average is 95.77, creating a Buy signal.
LGND Technical Analysis vs Fundamental Analysis
Sell
48
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals a Buy or a Sell?
-
Ligand Pharmaceuticals stock is rated a SellThe current Ligand Pharmaceuticals [LGND] share price is $113.38. The Score for LGND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Ligand Pharmaceuticals Stock Info
Market Cap:
2.1B
Price in USD:
113.38
Share Volume:
58.7K
Ligand Pharmaceuticals 52-Week Range
52-Week High:
129.90
52-Week Low:
67.53
Sell
48
Ligand Pharmaceuticals (LGND)
is a Sell
Ligand Pharmaceuticals Share Price Forecast
-
What is the Ligand Pharmaceuticals stock price today?The Ligand Pharmaceuticals stock price is 113.38 USD today.
-
Will LGND stock go up or go down?Ligand Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Ligand Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ligand Pharmaceuticals is overvalued.
Is Ligand Pharmaceuticals Stock a Buy?
-
Ligand Pharmaceuticals share price is 113.38 while LGND 8-day exponential moving average is 115.50, which is a Sell signal.
-
The stock price of LGND is 113.38 while Ligand Pharmaceuticals 20-day EMA is 116.95, which makes it a Sell.
-
Ligand Pharmaceuticals 50-day exponential moving average is 114.67 while LGND share price is 113.38, making it a Sell technically.
-
LGND stock price is 113.38 and Ligand Pharmaceuticals 200-day simple moving average is 99.24, creating a Buy signal.
Fundamental Analysis of Ligand Pharmaceuticals
Is Ligand Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.48 per share.
Technical Analysis of Ligand Pharmaceuticals
Should I short Ligand Pharmaceuticals stock?
-
LGND Moving Average Covergence Divergence (MACD) indicator is -0.5, suggesting Ligand Pharmaceuticals is a Sell
-
Ligand Pharmaceuticals Relative Strength Index (RSI) is 44.98, which suggest Ligand Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Ligand Pharmaceuticals is (114.3 - 122.38), which suggest Ligand Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Ligand Pharmaceuticals is (100.62 - 116.98), which suggest Ligand Pharmaceuticals is a Buy
* Ligand Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.